Vicarious Surgical(RBOT)
$0.02+0.00 (+11.11%)
RBOT
Vicarious Surgical financials statements
$0.02
At close:+0.00 (+11.11%)
Want to see RBOT full AI Analyst Report?
Vicarious Surgical (RBOT) Ratios
260 Followers
Vicarious Surgical Ratios
RBOT's free cash flow for Q1 2026 was $-6.33M. For the 2026 fiscal year, RBOT's free cash flow was decreased by $-9.00K and operating cash flow was $-6.33M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.97 | 6.74 | 13.87 | 14.35 | 28.56 |
| Quick Ratio | 2.97 | 6.74 | 13.87 | 14.35 | 28.56 |
| Cash Ratio | 0.66 | 1.27 | 7.26 | 13.85 | 27.78 |
| Solvency Ratio | -5.01 | -2.91 | -3.16 | 0.21 | -0.35 |
| Operating Cash Flow Ratio | -11.55 | -6.52 | -8.56 | -7.29 | -5.33 |
| Short-Term Operating Cash Flow Coverage | -85.86 | 0.00 | 0.00 | -3825.69 | -51.47 |
| Net Current Asset Value | $ 1.84M | $ 30.68M | $ 79.06M | $ 91.16M | $ 79.79M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.40 | 0.20 | 0.12 | 0.11 | 0.01 |
| Debt-to-Equity Ratio | 0.79 | 0.30 | 0.15 | 0.14 | 0.02 |
| Debt-to-Capital Ratio | 0.44 | 0.23 | 0.13 | 0.12 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Financial Leverage Ratio | 1.99 | 1.45 | 1.22 | 1.26 | 2.19 |
| Debt Service Coverage Ratio | -92.87 | 0.00 | -2767.68 | 29.94 | -47.29 |
| Interest Coverage Ratio | 0.00 | 0.00 | -3226.64 | -400.39 | -429.47 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.31 | 2.34 | 3.07 | 3.70 | 0.44 |
| Net Debt to EBITDA | -0.11 | -0.07 | 0.55 | -15.54 | 4.95 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 98.46% | 94.99% | 88.11% | -6.44% | 92.11% |
| Return on Assets (ROA) | -256.28% | -93.36% | -59.29% | 3.68% | -19.38% |
| Return on Equity (ROE) | -509.93% | -135.39% | -72.54% | 4.64% | -42.37% |
| Return on Capital Employed (ROCE) | -325.11% | -110.83% | -71.65% | -60.71% | -21.79% |
| Return on Invested Capital (ROIC) | -289.08% | -108.63% | -70.99% | -60.32% | -21.71% |
| Return on Tangible Assets | -256.28% | -93.36% | -59.29% | 3.68% | -19.38% |
| Earnings Yield | -389.43% | -81.62% | -133.66% | 1.98% | -3.43% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.59 | 1.81 | 1.47 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -228.99 | -201.99 | -247.66 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 228.99 | 201.99 | 247.66 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -7.59 | -8.49 | -12.89 | -14.26 | -10.34 |
| Free Cash Flow Per Share | -7.61 | -8.52 | -13.23 | -15.51 | -10.74 |
| Dividend Paid and CapEx Coverage Ratio | -341.48 | -277.53 | -37.31 | -11.44 | -25.83 |
| Capital Expenditure Coverage Ratio | -341.48 | -277.53 | -37.31 | -11.44 | -25.83 |
| Operating Cash Flow Coverage Ratio | -5.79 | -3.62 | -4.20 | -3.90 | -24.89 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -350.83% | -64.73% | -120.31% | -25.59% | -3.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.26 | -1.23 | -0.75 | 50.45 | -29.14 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 1.31 | 1.66 | 0.54 | 2.34 | 12.35 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.29 | -1.54 | -0.83 | -3.91 | -29.66 |
| Price-to-Operating Cash Flow Ratio | -0.29 | -1.55 | -0.85 | -4.25 | -30.81 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.05 | 0.00 | -0.45 | -0.15 |
| Enterprise Value Multiple | -0.37 | -1.33 | -0.22 | 24.68 | -24.53 |
| Enterprise Value | 18.11M | 81.51M | 15.18M | 159.63M | 853.72M |
| EV to EBITDA | -0.37 | -1.33 | -0.22 | 24.68 | -24.53 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.40 | -1.63 | -0.24 | -2.40 | -24.68 |
| EV to Operating Cash Flow | -0.40 | -1.63 | -0.24 | -2.61 | -25.64 |
| Tangible Book Value Per Share | 1.66 | 7.93 | 20.27 | 25.87 | 25.80 |
| Shareholders’ Equity Per Share | 1.66 | 7.93 | 20.27 | 25.87 | 25.80 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -8.45 | -10.74 | -14.70 | 1.20 | -10.93 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 0.96 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.90 | 0.79 | 0.88 | -11.87 | 0.95 |
Currency in USD
